American Ophthalmic Laboratories (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-12-2024
- Paid Up Capital ₹ 0.92 M
as on 14-12-2024
- Company Age 25 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.20 M
as on 14-12-2024
- Revenue -35.06%
(FY 2020)
- Profit -4.13%
(FY 2020)
- Ebitda 874.82%
(FY 2020)
- Net Worth 4.31%
(FY 2020)
- Total Assets -9.52%
(FY 2020)
About American Ophthalmic Laboratories (India)
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.92 M.
The company currently has active open charges totaling ₹0.20 M.
Srinivasan Narayanasamy and Venkatachalam Sarasvathi serve as directors at the Company.
- CIN/LLPIN
U85195TZ1999PTC008893
- Company No.
008893
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 1999
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at American Ophthalmic Laboratories (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasan Narayanasamy  | Director | 14-Jun-1999 | Current |
| Venkatachalam Sarasvathi | Director | 18-Oct-2021 | Current |
Financial Performance and Corporate Structure Insights of American Ophthalmic Laboratories (India).
American Ophthalmic Laboratories (India) Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 35.06% decrease. The company also saw a slight decrease in profitability, with a 4.13% decrease in profit. The company's net worth moved up by a moderate rise of 4.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of American Ophthalmic Laboratories (India)?
In 2018, American Ophthalmic Laboratories (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Krishna Terry Tex Private LimitedActive 32 years 2 monthsSrinivasan Narayanasamy and Venkatachalam Sarasvathi are mutual person
- K.R.S. Engineering India Private LimitedActive 14 years 9 months
Srinivasan Narayanasamy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 27 Feb 2004 | ₹0.20 M | Open |
How Many Employees Work at American Ophthalmic Laboratories (India)?
Unlock and access historical data on people associated with American Ophthalmic Laboratories (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of American Ophthalmic Laboratories (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped American Ophthalmic Laboratories (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
